Dakota Life Sciences Overview
- Founded
- 2010
- Status
- Public
- Stock Symbol
- KAST
Dakota Life Sciences General Information
Description
Kasten Inc is a United States-based biopharmaceutical company. It is principally focused on the acquisition, development, and commercialization of pharmaceuticals and devices designed to prevent and treat serious conditions arising in the hospital and adjacent clinical settings. The company focuses on offering solutions to people affected by antimicrobial resistance and providing pharmaceutical products at affordable prices.
Contact Information
Website
Formerly Known As
Pharmacline
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
PINX
Primary Office
- 2329 North Career Avenue
- Suite 206
- Sioux Falls, SD 57107
- United States
Dakota Life Sciences Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| 29.2K |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Dakota Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Dakota Life Sciences‘s full profile, request access.
Request a free trialDakota Life Sciences Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Steven Keough JD | President, Founder and Chief Executive Officer |